Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute in Melbourne Australia. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses; the ultimate aim being to eliminate these infections. Margaret is a member of numerous advisory committees including Co-Chairing the WHO STAC on HIV, viral hepatitis and STIs.

Doctor Rachel Sacks-Davis is a Research Fellow at the Burnet Institute and the Senior Manager of the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).

Professor Gail Matthews is Head of the Therapeutic Vaccine and Research Program (TVRP) at the Kirby Institute, UNSW as well as Head of Infectious Diseases at St Vincent’s Hospital. She has a strong background in HIV, viral hepatitis and strategic therapeutic clinical trials. As head of TVRP she leads several international clinical trials in HIV and COVID-19, as well as national projects in HCV and HBV. She works clinically as a specialist in HIV, Infectious Diseases and Viral Hepatitis at St Vincent’s Hospital, Sydney.

Dr. Marina Klein is a Professor of Medicine at McGill University, in the Division of Infectious Diseases/Chronic Viral Illnesses Service where she is Research Director and leads the MI4 Clinical Research Platform. She is National co-director of the Canadian Institutes of Health Research (CIHR) – Canadian HIV Trials Network (CTN) and holds a Tier 1 Canada Research Chair in Clinical and Epidemiologic Studies of Chronic Viral Infections in Vulnerable Populations. Dr Klein is leading “Métropoles sans Hep C“, an innovative community-focused program aiming to make Montreal the first city in North America to eliminate HCV.

Jacob Cumming is a research assistant at the Burnet Institute in Melbourne, studying a Master's of Mathematics (Statistics). He has a keen interest in using mathematics to shape policies resulting in better health outcomes.